ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added positive. The stock carries a Zacks Rank #2 ...
ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results